三翼杯桥接巨大髋臼缺损:10至28年结果
本研究回顾了1992年至2009年间233例(241髋)接受定制三翼杯髋臼组件植入的患者,骨缺损均为Paprosky IIIA、IIIB或IV型。84例(88髋)获得至少10年随访(平均15.2年,范围10至28年)或10年内失败,组件保留率为89%,43髋(49%)需再次手术。
要点
- 定制三翼杯用于Paprosky IIIA、IIIB或IV型巨大髋臼缺损,平均随访15.2年组件保留率89%。
- 43髋(49%)出现需再次手术的并发症,10髋(11.4%)因失败翻修。
- 翻修原因包括复发性感染4髋、无菌性松动3髋、复发性感染伴新三翼杯翻修1髋。
核心结论
- 定制三翼杯在平均15年随访中显示出优异的生存率和临床结果,组件保留率为89%。
研究设计与样本
- 回顾性识别1992年1月至2009年12月所有接受定制三翼杯髋臼组件植入的患者,共233例(241髋),骨缺损均为Paprosky IIIA、IIIB或IV型;84例(88髋)随访至少10年(平均15.2年,范围10至28年)或10年内失败。
主要发现
- 43髋(49%)出现需再次手术的并发症。
- 10髋(11.4%)因失败翻修,其中4髋因复发性感染、3髋因无菌性松动、1髋因复发性感染伴新三翼杯翻修。
- 1例因感染行Girdlestone切除,1例因感染伴连续性愈合翻修为双极半髋。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Massive acetabular bone loss, encountered complex primary or revision total hip arthroplasty, remains a reconstructive challenge. The custom triflange cup reliably achieves both early fixation and longer-term stability. This study presents the 10-year minimum three-surgeon follow-up of acetabular defects managed with a custom triflange component. METHODS: All patients who underwent a custom triflange acetabular component implantation from January 1992 to December 2009 were identified. Demographics, implant data, outcomes, and reoperations were collected and analyzed. Bone defects in all cases were Paprosky type IIIA, IIIB, or IV. A total of 233 patients (241 hips) underwent implantation of a custom triflange during the study period. There were 81 patients (83 hips) who died prior to minimum follow-up and 84 patients (88 hips) had minimum follow-up of 10 years (mean 15.2; range, 10 to 28), or failure prior to 10 years. RESULTS: Complications requiring additional surgery occurred in 43 hips (49%). There were 10 revisions for failure (11.4%); four were due to recurrent infection, three for aseptic loosening, and one for recurrent infection with all revised to a new triflange. There was one patient who was resected to a Girdlestone for infection and one patient was revised for infection to a bipolar hemiprosthesis due to a healed discontinuity. CONCLUSION: To our knowledge, this study represents the largest cohort and longest follow-up in the current literature and demonstrates excellent survivorship and clinical results at an average of 15 years follow-up. The component was retained in 89% of cases.
引用
- Christie MC, DeBoer DK, Morrison JC, et al. Bridging Massive Acetabular Defects With the Triflange Cup: 10- to 28-Year Results. J Arthroplasty. 2023. PMID: 37271239. doi:10.1016/j.arth.2023.05.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。